Comparison of the Diagnostic Accuracy of Hysterosalpingo-lidocaine-foam

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

This is a cross-sectional study that compares the diagnostic accuracy of Hysterosalpingo-lidocaine-foam sonography combined with power doppler (HyLiFoSy-PD) in the assessment of tubal patency, with the diagnostic accuracy of hysterosalpingogram (HSG), and to the gold standard of laparoscopy and dye testing.

See also
	Status	Clinical Trial	Phase
	Active, not recruiting	`NCT04139629` - Cohort Study Investigating the Association Between Antichlamydial Antibody Positivity and ART Outcomes in Women With TFI	N/A
	Completed	`NCT03476759` - Laparoscopic Tubal Adhesiolysis Versus IVF-ICSI	N/A

NCT number	NCT05419921
Study type	Observational
Source	Cairo University
Contact	Islam T. Elkhateb, M.Sc.
Phone	00201021656385
Email	islamtarekhamed@gmail.com
Status	Recruiting
Phase
Start date	July 1, 2022
Completion date	September 30, 2024

Comparison of the Diagnostic Accuracy of Hysterosalpingo-lidocaine-foam Sonography Versus Hysterosalpingography in Tubal Patency Assessment to the Gold Standard of Laparoscopy and Dye Testing

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms